Skip to main content

Advertisement

SpringerLink
Log in

Importance of a multidisciplinary approach for the treatment of Barrett’s esophagus

  • Review Article
  • Published:
Updates in Surgery Aims and scope Submit manuscript

Abstract

Barrett’s esophagus is a consequence of gastroesophageal reflux disease. Today, it is the most common cause of esophageal adenocarcinoma. Cancer is usually the end results of a cascade of events whereby metaplasia changes into low- and high-grade dysplasia and eventually cancer. Today, we have the unique opportunity to block this cascade and avoid the development of esophageal cancer. A multidisciplinary approach with a team composed of radiologists, gastroenterologists, pathologists, and surgeons allows individualization of care and the best results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

GERD:

Gastroesophageal reflux disease

RFA:

Radiofrequency ablation

EMR:

Endoscopic mucosal resection

HGD:

High-grade dysplasia

BE:

Barrett’s esophagus

LES:

Lower esophageal sphincter

TLESR:

Transient lower esophageal sphincter relaxation

PPIs:

Proton pump inhibitors

BMI:

Body mass index

IMC:

Intramucosal carcinoma

References

  1. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd (1997) Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112:1448–1456

    Article  PubMed  Google Scholar 

  2. Patti MG, Arcerito M, Feo CV, Worth S, De Pinto M, Gibbs VC, Gantert W, Tyrrell D, Ferrell LF, Way LW (1999) Barrett’s esophagus: a surgical disease. J Gastrointest Surg 3:397–403

    Article  PubMed  CAS  Google Scholar 

  3. Pohl H, Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97:142–146

    Article  PubMed  Google Scholar 

  4. Diener U, Patti MG, Molena D, Fisichella PM, Way LW (2001) Esophageal dysmotility and gastroesophageal reflux disease. J Gastrointest Surg 5:260–265

    Article  PubMed  CAS  Google Scholar 

  5. Patti MG, Perretta S (2003) Gastro-oesophageal reflux disease: a decade of changes. Asian J Surg 26:4–6

    Article  PubMed  Google Scholar 

  6. Herbella FA, Tedesco P, Nipomnick I, Fisichella PM, Patti MG (2007) Effect of partial and total laparoscopic fundoplication on esophageal body motility. Surg Endosc 21:285–288

    Article  PubMed  CAS  Google Scholar 

  7. Kahrilas PJ (1997) Anatomy and physiology of the gastroesophageal junction. Gastroenterol Clin N Am 26:467–486

    Article  CAS  Google Scholar 

  8. Zaninotto G, DeMeester TR, Schwizer W, Johansson KE, Cheng SC (1988) The lower esophageal sphincter in health and disease. Am J Surg 155:104–111

    Article  PubMed  CAS  Google Scholar 

  9. Patti MG, Gantert W, LW Way (1997) Surgery of the esophagus anatomy and physiology. Surg Clin N Am 77:959–970

    Article  PubMed  CAS  Google Scholar 

  10. Patti MG, Goldberg HI, Arcerito M, Bortolas L, Tong J, Way LW (1996) Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury. Am J Surg 171:182–186

    Article  PubMed  CAS  Google Scholar 

  11. Tack J, Koek G, Demedts I, Sifrim D, Janssens J (2004) Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett’s esophagus: acid reflux, bile reflux, or both? Am J Gastroenterol 99:981–988

    Article  PubMed  CAS  Google Scholar 

  12. Agrawal A, Roberts J, Sharma N, Tutuian R, Vela M, Castell DO (2009) Symptoms with acid and nonacid reflux may be produced by different mechanisms. Dis Esophagus 22:467–470

    Article  PubMed  CAS  Google Scholar 

  13. Peters JH, Avisar N (2010) The molecular pathogenesis of Barrett’s esophagus: common signaling pathways in embryogenesis metaplasia and neoplasia. J Gastrointest Surg 14(Suppl 1):S81–S87

    Article  PubMed  Google Scholar 

  14. Theisen J, Peters JH, Fein M, Hughes M, Hagen JA, Demeester SR, Demeester TR, Laird PW (2005) The mutagenic potential of duodenoesophageal reflux. Ann Surg 241:63–68

    PubMed  Google Scholar 

  15. Katz PO, Zavala S (2010) Proton pump inhibitors in the management of GERD. J Gastrointest Surg 14(Suppl 1):S62–S66

    Article  PubMed  Google Scholar 

  16. Tamhankar AP, Peters JH, Portale G, Hsieh CC, Hagen JA, Bremner CG, DeMeester TR (2004) Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology. J Gastrointest Surg 8:890–897

    Article  PubMed  Google Scholar 

  17. Blonski W, Vela MF, Castell DO (2009) Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy. J Clin Gastroenterol 43:816–820

    Article  PubMed  Google Scholar 

  18. Lindeboom MY, Ringers J, van Rijn PJ, Neijenhuis P, Stokkel MP, Masclee AA (2004) Gastric emptying and vagus nerve function after laparoscopic partial fundoplication. Ann Surg 240:785–790

    Article  PubMed  Google Scholar 

  19. Herbella FA, Sweet MP, Tedesco P, Nipomnick I, Patti MG (2007) Gastroesophageal reflux disease and obesity. Pathophysiology and implications for treatment. J Gastrointest Surg 11:286–290

    Article  PubMed  Google Scholar 

  20. Sweet MP, Patti MG, Hoopes C, Hays SR, Golden JA (2009) Gastro-oesophageal reflux and aspiration in patients with advanced lung disease. Thorax 64:167–173

    Article  PubMed  CAS  Google Scholar 

  21. Vela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO (2001) Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 120:1599–1606

    Article  PubMed  CAS  Google Scholar 

  22. Dallemagne B, Weerts J, Markiewicz S, Dewandre JM, Wahlen C, Monami B, Jehaes C (2006) Clinical results of laparoscopic fundoplication at ten years after surgery. Surg Endosc 20:159–165

    Article  PubMed  CAS  Google Scholar 

  23. Meneghetti AT, Tedesco P, Galvani C, Gorodner MV, Patti MG (2008) Outcomes after laparoscopic Nissen fundoplication are not influenced by the pattern of reflux. Dis Esophagus 21:165–169

    Article  PubMed  CAS  Google Scholar 

  24. Tedesco P, Lobo E, Fisichella PM, Way LW, Patti MG (2006) Laparoscopic fundoplication in elderly patients with gastroesophageal reflux disease. Arch Surg 141:289–292

    Article  PubMed  Google Scholar 

  25. Patti MG, Robinson T, Galvani C, Gorodner MV, Fisichella PM, Way LW (2004) Total fundoplication is superior to partial fundoplication even when esophageal peristalsis is weak. J Am Coll Surg 198:863–869

    Article  PubMed  Google Scholar 

  26. Patterson N, Mainie I, Rafferty G, McGarvey L, Heaney L, Tutuian R, Castell D, Johnston BT (2009) Nonacid reflux episodes reaching the pharynx are important factors associated with cough. J Clin Gastroenterol 43:414–419

    Article  PubMed  Google Scholar 

  27. Corley DA, Kubo A, Zhao W, Quesenberry C (2010) Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology 139:93–101

    Article  PubMed  Google Scholar 

  28. Katzka DA, Castell DO (1994) Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett’s esophagus. Am J Gastroenterol 89:989–991

    PubMed  CAS  Google Scholar 

  29. Wetscher GJ, Gadenstaetter M, Klingler PJ, Weiss H, Obrist P, Wykypiel H, Klaus A, Profanter C (2001) Efficacy of medical therapy and antireflux surgery to prevent Barrett’s metaplasia in patients with gastroesophageal reflux disease. Ann Surg 234:627–632

    Article  PubMed  CAS  Google Scholar 

  30. Oelschlager BK, Barerca M, Chang L, Oleynikov D, Pellegrini CA (2003) Clinical and pathologic response of Barrett’s esophagus to laparoscopic antireflux surgery. Ann Surg 238:458–464

    PubMed  Google Scholar 

  31. Ell C, May A, Pech O, Gossner L, Guenter E, Behrens A, Nachbar L, Huijsmans J, Vieth M, Stolte M (2007) Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest Endosc 65:3–10

    Article  PubMed  Google Scholar 

  32. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK et al (2009) Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 360:2277–2288

    Article  PubMed  CAS  Google Scholar 

  33. Weston AP, Sharma P, Topalovsky M, Richards R, Cherian R, Dixon A (2000) Long-term follow-up of Barrett’s high grade dysplasia. Am J Gastroenterol 95:1888–1893

    Article  PubMed  CAS  Google Scholar 

  34. Reid BJ, Blount PL, Feng Z, Levine DS (2000) Optimizing endoscopic biopsy detection of early cancers in Barrett’s high grade dysplasia. Am J Gastroenterol 95:3089–3096

    Article  PubMed  CAS  Google Scholar 

  35. Konda VJ, Ross AS, Ferguson MK, Hart JA, Lin S, Naylor K, Noffsinger A, Posner MC, Dye C, Cislo B, Stearns L, Waxman I (2008) Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett’s Esophagus overestimated? Clin Gastroenterol Hepatol 6:159–164

    Article  PubMed  Google Scholar 

  36. Penanthur A, Farkas A, Krasinskas Am, Ferson PF, Gooding WE, Gibson MK, Schuchert MJ, Landreneau RJ, Luketich JD (2009) Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg 87:1048–1055

    Article  Google Scholar 

  37. Pech O, Beherens A, May A, Nachbar L, Gossner L, Rabenstein T, Manner H, Guenter E, Huijsmans J, Vieth M, Stolte M, Ell C (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 57:1200–1206

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Surgery, Institute of Clinical Surgery, University of Ferrara and University Hospital of Ferrara, Ferrara, Italy

    Carlo V. Feo

  2. Department of Surgery, University of Chicago Pritzker School of Medicine, 5841 S. Maryland Ave, MC 5095, Room G-201, Chicago, IL, 60637, USA

    Marco G. Patti

Authors
  1. Carlo V. Feo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marco G. Patti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marco G. Patti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feo, C.V., Patti, M.G. Importance of a multidisciplinary approach for the treatment of Barrett’s esophagus. Updates Surg 63, 5–9 (2011). https://doi.org/10.1007/s13304-011-0049-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13304-011-0049-8

Keywords

Search

Navigation